Article
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Biochemical and biophysical research communications - 11 Aug 2000
Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S
Abstract excerpt
Patients with familial amyloid polyneuropathy (FAP) are now cured by liver transplantation, but cardiac amyloidosis would further progress even after liver transplantation in some patients. To clarify the pathological mechanism of the progress of cardiac amyloidosis in FAP, we investigated cardiac tissues obtained from 6 FAP patients with 3 different types of TTR mutations. One of them had undergone liver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
